| 发明名称 |
A TOR KINASE INHIBITOR IN THE PREVENTION OR TREATMENT OF CANCER CHARACTERIZED BY GENE MUTATIONS. |
| 摘要 |
Provided herein are methods for treating and/or preventing a cancer in a patient, comprising administering an effective amount of a TOR kinase inhibitor to a patient having cancer characterized by particular gene mutation(s) or variant(s) relative to the genes of a biological wild-type sample. |
| 申请公布号 |
MX2016004212(A) |
申请公布日期 |
2016.07.11 |
| 申请号 |
MX20160004212 |
申请日期 |
2014.10.03 |
| 申请人 |
SIGNAL PHARMACEUTICALS, LLC |
发明人 |
SHUICHAN XU;KRISTEN MAE HEGE;XIAOLING WU;ZHIHONG YANG;KONSTANTINOS MAVROMMATIS;ELLEN FILVAROFF;TAO SHI |
| 分类号 |
A61K31/00;A61K31/4985 |
主分类号 |
A61K31/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
